Harvard Bioscience (HBIO) Operating Income (QoQ) (2010 - 2026)
Harvard Bioscience (HBIO) Operating Income (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 151.46 Bn | 147.07 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 43.06 Bn | 42.04 Bn | 2.15 Bn |
| 3 | Medline | 29.49 Bn | 35.33 Bn | 1.84 Bn |
| 4 | Resmed | 28.58 Bn | 26.92 Bn | 890.98 Mn |
| 5 | West Pharmaceutical Services | 24.11 Bn | 23.59 Bn | 296.40 Mn |
| 6 | Solventum | 14.37 Bn | 14.37 Bn | 1.10 Bn |
| 7 | Cooper Companies | 13.38 Bn | 13.25 Bn | 735.40 Mn |
| 8 | Align Technology | 12.72 Bn | 11.66 Bn | 736.59 Mn |
| 9 | Baxter International | 10.32 Bn | 8.27 Bn | 891.00 Mn |
| 10 | Harvard Bioscience | 27.73 Mn | 20.63 Mn | 12.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -103.06% |
| Dec 31, 2025 | 19,355.33% |
| Sep 30, 2025 | 124.05% |
| Jun 30, 2025 | 98.35% |
| Mar 31, 2025 | -1,416.76% |
| Dec 31, 2024 | 301.28% |
| Sep 30, 2024 | 9.42% |
| Jun 30, 2024 | 9.21% |
| Mar 31, 2024 | -6.05% |
| Dec 31, 2023 | -130.33% |
| Sep 30, 2023 | -217.21% |
| Jun 30, 2023 | -54.49% |
| Mar 31, 2023 | -61.55% |
| Dec 31, 2022 | 220.92% |
| Sep 30, 2022 | -194.10% |
| Jun 30, 2022 | 159.56% |
| Mar 31, 2022 | -495.06% |
| Dec 31, 2021 | 210.04% |
| Sep 30, 2021 | 844.83% |
| Jun 30, 2021 | 124.27% |